RIJ to Market Sloning's Gene Synthesis Services in Japan | GenomeWeb
NEW YORK (GenomeWeb News) — Sloning Biotechnology of Puchheim, Germany, on Monday said that Research and Innovation Japan will exclusively market and distribute its Slonomics gene-synthesis service and its Slonomax gene-mutant libraries in Japan.
 
“Sloning's products and services perfectly address the current demand in genomics research and protein engineering,” RIJ CEO Kiyohiko Hirasawa said in a statement.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.